Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anacetrapib in CHD (DEFINE)
NCT00685776Phase 3Completed
- Sponsor
- Merck & Co.
- Start
- Mar 2008
- Primary completion
- Jul 2009
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of anacetrapib in coronary heart disease (CHD), hypercholesterolemia, sponsored by Merck & Co.. Started Mar 2008; status: completed.
02
Drugs
anacetrapib
03
Conditions
coronary heart disease (CHD)hypercholesterolemia
Beyond the preview
Go deeper on NCT00685776.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00685776.